Figure 3From: Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkersSPP1 clinical outcome evaluation. SPP1 showed a significant (p < 0.05) poor outcome in case of over-expression for both survival, in test (A) and validation data sets (C), and metastasis formation, in test (B) and validation data sets (D).Back to article page